NCT00377546已完成4 期
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
To compare the penetration of three different NSAIDs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males or females scheduled to undergo Vitrectomy surgery
- •Likely to complete all study visits and able to provide informed consent
- •Visual potential of 20/25 or better
排除标准
- •Known contraindications to any study medication or ingredients
- •Active ocular diseases or uncontrolled systemic disease
- •Active ocular allergies
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy VolunteersEye Infections, BacterialNCT00357292Laboratoires Thea
已完成
4 期
Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRKMyopiaHyperopiaNCT00347204Center For Excellence In Eye Care40
已完成
1 期
Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy VolunteersEye Infections, BacterialNCT00357539Laboratoires Thea
Unknown
4 期
Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)PainNCT00869219Santa Casa de Misericordia de Santos40
撤回
3 期
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)Age Related Macular DegenerationNCT00557791OPKO Health, Inc.